Stock listing
SIX Swiss:IDIA Idorsia Ltd. Aktie
Home listing (SIX Swiss) of Idorsia Ltd.
Follow Idorsia Ltd. into a list and get an email when it puts out news.
Share price · SIX:IDIA
3.59 CHF -0.25 (-6.6%)
Close on Nov 20, 2026
- Day range
- 3.53 – 3.72 CHFNov 20, 2026
- Volume
- 783,165 sharesNov 20, 2026
- Market cap
- 967.4M CHFAt the close on Nov 20, 2026 · price × 269.8M shares outstanding
- 52-week range
- 2.80 – 7.56 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 4.33M CHFMedian day 743,681 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:IDIA · Home | 3.586 CHF | -0.254 (-6.6%) | 783,165 | 3.71 | 3.72 | 3.53 | 3.84 | Close on Nov 20, 2026 |
| OTC:IDRSF | $4.20 USD | -0.50 (-10.6%) | 300 | $4.20 | $4.20 | $4.20 | $4.70 | Close on Nov 20, 2026 |
| Frankfurt:19T | €3.926 EUR | -0.366 (-8.5%) | — | €3.988 | €3.988 | €3.926 | €4.292 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:IDIA · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 3.586 | -0.254 | -6.6% | 3.71 | 3.72 | 3.53 | 783,165 | |
| 3.84 | -0.13 | -3.3% | 3.958 | 3.98 | 3.82 | 315,324 | |
| 3.97 | -0.01 | -0.3% | 3.94 | 4.06 | 3.878 | 705,754 | |
| 3.98 | +0.072 | +1.8% | 3.86 | 4.042 | 3.86 | 1,064,432 | |
| 3.908 | -0.042 | -1.1% | 3.888 | 3.948 | 3.86 | 680,029 | |
| 3.95 | -0.064 | -1.6% | 4.014 | 4.05 | 3.802 | 1,393,304 | |
| 4.014 | -0.112 | -2.7% | 4.162 | 4.17 | 3.978 | 1,121,328 | |
| 4.126 | -0.028 | -0.7% | 4.20 | 4.224 | 4.11 | 344,005 | |
| 4.154 | +0.096 | +2.4% | 4.096 | 4.17 | 4.076 | 463,521 | |
| 4.058 | -0.142 | -3.4% | 4.132 | 4.132 | 3.99 | 997,202 | |
| 4.20 | -0.21 | -4.8% | 4.444 | 4.446 | 4.164 | 1,003,263 | |
| 4.41 | +0.078 | +1.8% | 4.468 | 4.488 | 4.27 | 853,235 | |
| 4.332 | +0.078 | +1.8% | 4.186 | 4.434 | 4.136 | 745,001 | |
| 4.254 | -0.216 | -4.8% | 4.466 | 4.47 | 4.178 | 1,173,910 | |
| 4.47 | -0.112 | -2.4% | 4.568 | 4.576 | 4.43 | 640,440 | |
| 4.582 | -0.01 | -0.2% | 4.368 | 4.624 | 4.262 | 1,157,486 | |
| 4.592 | +0.04 | +0.9% | 4.50 | 4.64 | 4.41 | 553,848 | |
| 4.552 | +0.212 | +4.9% | 4.40 | 4.57 | 4.364 | 732,390 | |
| 4.34 | +0.152 | +3.6% | 4.37 | 4.43 | 4.28 | 793,373 | |
| 4.188 | -0.048 | -1.1% | 4.246 | 4.246 | 4.122 | 364,227 | |
| 4.236 | -0.03 | -0.7% | 4.262 | 4.264 | 4.08 | 551,824 | |
| 4.266 | +0.022 | +0.5% | 4.25 | 4.30 | 4.212 | 350,763 | |
| 4.244 | +0.062 | +1.5% | 4.118 | 4.30 | 4.108 | 653,657 | |
| 4.182 | +0.082 | +2.0% | 4.03 | 4.182 | 3.992 | 629,570 | |
| 4.10 | -0.098 | -2.3% | 4.22 | 4.222 | 4.032 | 811,026 | |
| 4.198 | -0.038 | -0.9% | 4.18 | 4.222 | 4.132 | 742,360 | |
| 4.236 | +0.204 | +5.1% | 4.05 | 4.248 | 4.02 | 644,397 | |
| 4.032 | -0.368 | -8.4% | 4.25 | 4.308 | 4.032 | 1,460,523 | |
| 4.40 | +0.202 | +4.8% | 4.29 | 4.432 | 4.252 | 769,980 | |
| 4.198 | +0.148 | +3.7% | 4.134 | 4.198 | 3.932 | 1,213,731 | |
| 4.05 | -0.286 | -6.6% | 4.284 | 4.284 | 4.05 | 1,361,055 | |
| 4.336 | -0.064 | -1.5% | 4.354 | 4.376 | 4.202 | 739,217 | |
| 4.40 | -0.068 | -1.5% | 4.60 | 4.648 | 4.298 | 1,464,480 | |
| 4.468 | +0.01 | +0.2% | 4.47 | 4.51 | 4.37 | 608,362 | |
| 4.458 | -0.104 | -2.3% | 4.514 | 4.596 | 4.45 | 656,402 | |
| 4.562 | -0.084 | -1.8% | 4.638 | 4.696 | 4.508 | 793,660 | |
| 4.646 | +0.208 | +4.7% | 4.468 | 4.646 | 4.404 | 736,536 | |
| 4.438 | +0.058 | +1.3% | 4.414 | 4.574 | 4.368 | 917,350 | |
| 4.38 | -0.058 | -1.3% | 4.438 | 4.492 | 4.334 | 940,999 | |
| 4.438 | +0.076 | +1.7% | 4.406 | 4.438 | 4.36 | 1,259,715 | |
| 4.362 | -0.206 | -4.5% | 4.55 | 4.576 | 4.348 | 2,084,039 | |
| 4.568 | -0.168 | -3.5% | 4.75 | 4.832 | 4.568 | 1,345,837 | |
| 4.736 | -0.06 | -1.3% | 4.80 | 4.876 | 4.724 | 923,237 | |
| 4.796 | -0.04 | -0.8% | 4.812 | 4.848 | 4.75 | 697,364 | |
| 4.836 | -0.064 | -1.3% | 4.94 | 5.04 | 4.81 | 7,781,564 | |
| 4.90 | -0.05 | -1.0% | 5.00 | 5.04 | 4.88 | 581,978 | |
| 4.95 | +0.192 | +4.0% | 4.782 | 4.952 | 4.752 | 737,733 | |
| 4.758 | -0.24 | -4.8% | 4.906 | 5.05 | 4.60 | 1,186,721 | |
| 4.998 | -0.002 | 0.0% | 4.95 | 5.075 | 4.886 | 711,884 | |
| 5.00 | -0.02 | -0.4% | 5.03 | 5.11 | 4.952 | 501,849 | |
| 5.02 | -0.095 | -1.9% | 5.18 | 5.205 | 5.015 | 387,585 | |
| 5.115 | -0.01 | -0.2% | 5.08 | 5.165 | 5.035 | 317,644 | |
| 5.125 | +0.045 | +0.9% | 5.195 | 5.20 | 4.98 | 377,488 | |
| 5.08 | +0.084 | +1.7% | 4.98 | 5.105 | 4.96 | 661,462 | |
| 4.996 | -0.174 | -3.4% | 5.17 | 5.205 | 4.996 | 500,681 | |
| 5.17 | -0.025 | -0.5% | 5.265 | 5.40 | 5.17 | 493,383 | |
| 5.195 | +0.11 | +2.2% | 5.085 | 5.39 | 5.085 | 909,892 | |
| 5.085 | +0.145 | +2.9% | 4.938 | 5.085 | 4.90 | 887,960 | |
| 4.94 | -0.395 | -7.4% | 5.25 | 5.30 | 4.94 | 2,491,922 | |
| 5.335 | -0.415 | -7.2% | 5.745 | 5.82 | 5.335 | 991,694 | |
| 5.75 | +0.075 | +1.3% | 5.67 | 5.88 | 5.67 | 644,450 | |
| 5.675 | +0.105 | +1.9% | 5.585 | 5.765 | 5.585 | 674,046 | |
| 5.57 | +0.195 | +3.6% | 5.44 | 5.595 | 5.40 | 594,248 | |
| 5.375 | -0.175 | -3.2% | 5.50 | 5.505 | 5.275 | 856,356 | |
| 5.55 | -0.05 | -0.9% | 5.55 | 5.63 | 5.38 | 948,671 | |
| 5.60 | -0.19 | -3.3% | 5.90 | 6.00 | 5.53 | 861,214 |
- Ticker
- SIX Swiss:IDIA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- SIX Swiss
- Currency
- CHF
What changed lately
Latest news release · Oct 29, 2026
Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance
Latest earnings call · Jul 30, 2026
Idorsia (SIX Swiss: IDIA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Investor Presentation (November 2026)
Investor deck · 31 slides
Calls
Replays
Idorsia (SIX Swiss: IDIA) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 9:00 AM ET
Watch TranscriptIdorsia (SIX Swiss: IDIA) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch TranscriptIdorsia (SIX Swiss: IDIA) Q2 2025 Earnings Call
Wed, Jul 30, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance
Oct 29, 2026
Closed 4.58 (-0.2%) on Oct 29, 2026
Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists
Oct 29, 2026
Closed 4.58 (-0.2%) on Oct 29, 2026
Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera
Oct 28, 2026
Closed 4.59 (+0.9%) on Oct 28, 2026
Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
Oct 23, 2026
Closed 4.34 (+3.6%) on Oct 26, 2026
Idorsia acknowledges the DEA proposal to reclassify dual orexin receptor antagonists to the lowest schedule – Schedule V
Aug 11, 2026
Closed 6.51 (+9.7%) on Aug 11, 2026
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
Jul 30, 2026
Closed 6.21 (-5.0%) on Jul 30, 2026
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Jul 27, 2026
Closed 6.63 (+7.5%) on Jul 27, 2026
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
Jul 23, 2026
Closed 6.17 (+1.5%) on Jul 24, 2026
Idorsia appoints Roland Wandeler as Chief Executive Officer
Jul 1, 2026
Closed 6.61 (-3.8%) on Jul 1, 2026
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Jun 26, 2026
Closed 6.86 (+14.0%) on Jun 26, 2026
Financings
New Notes of Idorsia Investments SARL with 12% earn-out
Oct 29, 2026 · US$86.78M
Announced: CHF 72M
Use of proceeds: Launch capital for TRYVIO/JERAYGO: a focused US launch and phased commercialization in Europe and Canada
Private placement of registered shares (new and treasury shares)
Oct 10, 2025 · US$81.69M
Closed: CHF 65.6M raised · CHF 4 a share
Buyers: Jean-Paul and Martine Clozel (Offer Shares for an aggregate amount of up to CHF 10 million)
Insiders: Founding shareholders Jean-Paul and Martine Clozel committed to buy Offer Shares at the offer price for up to CHF 10 million, with a 180-day lockup
Use of proceeds: Strengthen balance sheet, accelerate QUVIVIQ commercial trajectory, advance pipeline, and general corporate purposes
Shares (equity line)
Aug 27, 2025
Update: raise
Use of proceeds: To further extend the cash runway into 2027
New money facility
May 21, 2025 · US$181.85M
Update: CHF 150M · Warrants at CHF 1.5
Use of proceeds: Extend cash runway to mid-2026
Announced Feb 26, 2025 · Update Mar 4, 2025 · Update May 21, 2025
Private placement of shares
Feb 26, 2025
Announced: private placement
Use of proceeds: Additional capital to meet its obligations
Decks
Investor Presentation (November 2026)
Investor deck · 31 slides · Nov 4, 2026
Sleep Europe 2026
Conference · 22 slides · Oct 23, 2026
Investor Presentation (October 2026)
Investor deck · 48 slides · October 2026
Fact Sheet (September 2026)
Fact sheet · 5 slides · Sep 30, 2026
Idorsia Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 33 in the last 12 months · 76 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 16 calls with a replay · 16 with a transcript · latest Jul 30, 2026
- Decks
- 55 decks · latest Nov 4, 2026
Where Idorsia Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:IDIA · Home listing · This page | SIX Swiss | Switzerland | CHF |
| LSIN:0RQE | LSIN | United Kingdom | CHF |
| OTC:IDRSF | OTC | United States | USD |
| Lang & Schwarz:A2DTEB | Lang & Schwarz | Germany | EUR |
| gettex:19T | gettex | Germany | EUR |
| LS Exchange:A2DTEB | LS Exchange | Germany | EUR |
| BX Swiss:19T | BX Swiss | Switzerland | CHF |
| Tradegate:19T | Tradegate | Germany | EUR |
| Aquis:IDIAZ | Aquis | United Kingdom | CHF |
| Frankfurt:19T | Frankfurt | Germany | EUR |
| Turquoise:IDIAZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:19T | Dusseldorf | Germany | EUR |
| Hamburg:19T | Hamburg | Germany | EUR |
| Munich:19T | Munich | Germany | EUR |
| Stuttgart:19T | Stuttgart | Germany | EUR |
| Hanover:19T | Hanover | Germany | EUR |
| Xetra:19T | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Idorsia Ltd.